Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon May 04, 2022 11:34am
172 Views
Post# 34655138

RE:Last chance

RE:Last chanceIn the past we have all tried to guess what was enough data to impress the FDA, when we might get BTD etc. but in the last report we have gotten more clarity, no more guessing in a sense. The 'bad news' is BTD isn't likely until Oct-Dec but the good news is it is almost definitely likely by then with AA hopefully right around the corner from that.

Day traders sold the 'bad news' because they don't want to wait 5-8 months, too bad for them, but for investors it looks like we finally have a date by which we could see real value reflected in the stock. Patients have been treated so no delays, no dosing missteps, just waiting for the data to roll in and hoping the trend continues. Vaccine and other research continuing and Roger buying because he knows what he has put together here.

And there is always the chance we could get something out of the blue to cause pain for the sellers/shorts. I think I would like that. 
<< Previous
Bullboard Posts
Next >>